Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 3/20 | 0.46 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | BCR | P11274 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 3/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1243178 | 0.93 | STS (0.51) | STSCISD1CA2CA9CA1 | |
| SCHEMBL29812596 | 0.93 | STS (0.51) | STSCISD1CA2CA9CA1 | |
| Naphthalene SCHEMBL10357718 | 0.86 | STS (0.50) | STSCISD1CA2CA9CA1 | |
| SCHEMBL9664445 | 0.84 | CA1 (0.60) | STSCISD1CA2CA9CA1 | |
| SCHEMBL30526137 | 0.81 | CISD1 (0.56) | CISD1CA2CA9CA1CYP3A4 | |
| Propionic Acid SCHEMBL28865642 | 0.80 | CYP3A4 (0.47) | STSCISD1CYP3A4LMNACA5A | |
| SCHEMBL8006865 | 0.77 | STS (0.49) | STSCA2CA9CA1CYP3A4 | |
| SCHEMBL16028280 | 0.76 | STS (0.48) | STSCA2CA9CA1CYP3A4 | |
| SCHEMBL14015386 | 0.76 | STS (0.54) | STSCA2CA9CA1CYP3A4 | |
| SCHEMBL5664523 | 0.76 | ALDH1A1 (0.54) | STSCA2CA9CA1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250162986-A1 | Compounds and compositions for neurodegenerative diseases | UNIVERSIDADE NOV A DE LISBOA (PT) | 2025-05-22 | — | — | US | disclosed |
| EP-4482483-A1 | COMPOUNDS AND COMPOSITIONS FOR NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2025-01-01 | — | — | EP | disclosed |
| CN-118742304-A | Compounds and compositions for neurodegenerative diseases | 里斯本新大学 | 2024-10-01 | — | — | CN | disclosed |
| WO-2023156983-A1 | COMPOUNDS AND COMPOSITIONS FOR NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2023-08-24 | — | — | WO | disclosed |
| EP-4230201-A1 | COMPOSITION FOR TREATING NEURODEGENERATIVE DISEASES | UNIVERSIDADE NOVA DE LISBOA (PT) | 2023-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250162986-A1 | Compounds and compositions for neurodegenerative diseases | CLN6, HTT, SNCA | STS 4034/4885CISD1 2185/4885CA2 1205/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.